EU governments ban malaria drug for COVID-19, trial paused as safety fears grow
European governments moved on Wednesday to halt the use of anti-malaria drug hydroxychloroquine to treat COVID-19 patients, and a second global trial of it was suspended, further blows to hopes for a treatment promoted by U.S. President Donald Trump.
